European guidelines on perinatal care: corticosteroids for women at risk of preterm birth

References

• Salvante KG, Milano K, Kliman HJ, et al. Placental 11 beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) expression very early during human pregnancy. J Dev Orig Health Dis. 2017;8(2):149–154.
   PubMed Web of Science ®Google Scholar
• Murphy VE, Fittock RJ, Zarzycki PK, et al. Metabolism of synthetic steroids by the human placenta. Placenta. 2007;28(1):39–46.
   PubMed Web of Science ®Google Scholar
• Committee Opinion No.677: antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2016;128:e187-94.
   PubMedGoogle Scholar
• Boutin A, Skoll A, Bujold E, et al. Antenatal corticosteroid therapy for improving neonatal outcomes: balancing benefits and risks. J Obstet Gynaecol Can. 2018;40(9):1193–1197.
   PubMed Web of Science ®Google Scholar
• Good clinical practice advice. Antenatal corticosteroids for fetal lung maturation. Int J Gynaecol Obstet. 2019;144:352–355.
   PubMed Web of Science ®Google Scholar
• Modi N, Lewis H, Al-Naqeeb N, et al. The effects of repeated antenatal glucocorticoid therapy on the developing brain. Pediatr Res. 2001;50(5):581–585.
   PubMed Web of Science ®Google Scholar
• Melamed N, Asztalos E, Murphy K, et al. Neurodevelopmental disorders among term infants exposed to antenatal corticosteroids during pregnancy: a population-based study. BMJ Open. 2019;9(9):e031197.
   PubMed Web of Science ®Google Scholar
• Raikkonen K, Gissler M, Kajantie E. Associations between maternal antenatal corticosteroid treatment and mental and behavioral disorders in children. JAMA. 2020;323(19):1924–1933.
   PubMed Web of Science ®Google Scholar
• Asztalos E. Antenatal corticosteroids: a risk factor for the development of chronic disease. J Nutr Metab. 2012;2012:930591.
   PubMedGoogle Scholar
• Grzeskowiak LE, Grivell RM, Mol BW. Trends in receipt of single and repeat courses of antenatal corticosteroid administration among preterm and term births: a retrospective cohort study. Aust N Z J Obstet Gynaecol. 2017;57(6):643–650.
   PubMed Web of Science ®Google Scholar
• Levin HI, Ananth CV, Benjamin-Boamah C, et al. Clinical indication and timing of antenatal corticosteroid administration at a single Centre. BJOG. 2016;123(3):409–414.
   PubMed Web of Science ®Google Scholar
• Palas D, Ehlinger V, Alberge C, et al. Efficacy of antenatal corticosteroids in preterm twins: the EPIPAGE-2 cohort study. BJOG. 2018;125(9):1164–1170.
   PubMed Web of Science ®Google Scholar
• Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome - 2019 update. Neonatology. 2019;115(4):432–450.
   PubMed Web of Science ®Google Scholar
• Di Renzo GC, Roura LC, Facchinetti F, et al. Guidelines for the management of spontaneous preterm labor: identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes, and preventive tools for preterm birth. J Matern Fetal Neonatal Med. 2011;24(5):659–667.
   PubMed Web of Science ®Google Scholar
• Di Renzo GC, Cabero Roura L, Facchinetti F, et al. Preterm labor and birth management: recommendations from the european association of perinatal medicine. J Matern Fetal Neonatal Med. 2017;30(17):2011–2030.
   PubMed Web of Science ®Google Scholar
• McGoldrick E, Stewart F, Parker R, et al. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2020;12: CD004454.
   PubMedGoogle Scholar
• Antenatal dexamethasone for early preterm birth in Low-Resource countries. N Eng J Med. 2020;383:2514–2525.
   PubMed Web of Science ®Google Scholar
• Crowther CA, McKinlay CJ, Middleton P, et al. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst Rev. 2015;Cd003935.
   PubMed Web of Science ®Google Scholar
• Battarbee AN, Ros ST, Esplin MS, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Genomics and Proteomics Network for Preterm Birth Research (GPN-PBR), et al. Optimal timing of antenatal corticosteroid administration and preterm neonatal and early childhood outcomes. Am J Obstet Gynecol MFM. 2020;2(1):100077.
   PubMed Web of Science ®Google Scholar
• Sotiriadis A, Tsiami A, Papatheodorou S, et al. Neurodevelopmental outcome after a single course of antenatal steroids in children born preterm: a systematic review and meta-analysis. Obstet Gynecol. 2015;125(6):1385–1396.
   PubMed Web of Science ®Google Scholar
• Blankenship SA, Brown KE, Simon LE, et al. Antenatal corticosteroids in preterm small-for-gestational age infants: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020;2(4):100215.
   PubMed Web of Science ®Google Scholar
• Committee Opinion No. 713: antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2017;130:e102–e9.
   PubMed Web of Science ®Google Scholar
• UN Commission/Born Too soon Care Antenatal Corticosteroids Working Group. Dexamethasone versus betamethasone as an antenatal corticosteroid (ACS). 20 August 2013. Retrieved: July 2021.
   Google Scholar
• Crowther CA, Ashwood P, Andersen CC, ASTEROID Study Group, et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child Adolesc Health. 2019;3(11):769–780.
   PubMedGoogle Scholar
• Ciapponi A, Klein K, Colaci D, et al. Dexamethasone vs. betamethasone for preterm birth: a systematic review and network meta-analysis. Am J Obstet Gynecol MFM. 2021;3(3):100312.
   PubMed Web of Science ®Google Scholar
• Deshmukh M, Patole S. Antenatal corticosteroids in impending preterm deliveries before 25 weeks’ gestation. Arch Dis Child Fetal Neonatal Ed. 2018;103(2):F173–F176.
   PubMed Web of Science ®Google Scholar
• Dixon CL, Too G, Saade GR, et al. Past and present: a review of antenatal corticosteroids and recommendations for late preterm birth steroids. Am J Perinatol. 2018;35(13):1241–1250.
   PubMed Web of Science ®Google Scholar
• Hajdu SA, Rossi RM, DeFranco EA. Factors associated with maternal and neonatal interventions at the threshold of viability. Obstet Gynecol. 2020;135(6):1398–1408.
   PubMed Web of Science ®Google Scholar
• Norman M, Hallberg B, Abrahamsson T, et al. Association between year of birth and 1-Year survival among extremely preterm infants in Sweden during 2004–2007 and 2014–2016. JAMA. 2019;321(12):1188–1199.
   PubMed Web of Science ®Google Scholar
• Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379(9832):2162–2172.
   PubMed Web of Science ®Google Scholar
• Hibbard JU, Wilkins I, Sun L, Consortium on Safe Labor, et al. Respiratory morbidity in late preterm births. JAMA. 2010;304(4):419–425.
   PubMed Web of Science ®Google Scholar
• Cheng YW, Kaimal AJ, Bruckner TA, et al. Perinatal morbidity associated with late preterm deliveries compared with deliveries between 37 and 40 weeks of gestation. BJOG. 2011;118(12):1446–1454.
   PubMed Web of Science ®Google Scholar
• Malloy MH. Impact of cesarean section on intermediate and late preterm births: United States, 2000-2003. Birth. 2009;36(1):26–33.
   PubMed Web of Science ®Google Scholar
• Gyamfi-Bannerman C, Thom EA, Blackwell SC, NICHD Maternal–Fetal Medicine Units Network, et al. Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med. 2016;374(14):1311–1320.
   PubMed Web of Science ®Google Scholar
• Saccone G, Berghella V. Antenatal corticosteroids for maturity of term or near term fetuses: systematic review and meta-analysis of randomized controlled trials. BMJ. 2016;355:i5044–i.
   PubMed Web of Science ®Google Scholar
• Ninan K, Liyanage SK, Murphy KE, et al. Evaluation of long-term outcomes associated with preterm exposure to antenatal corticosteroids: a systematic review and meta-analysis. JAMA Pediatr. 2022;176(6):e220483.
   PubMed Web of Science ®Google Scholar
• Sotiriadis A, Makrydimas G, Papatheodorou S, et al. Corticosteroids for preventing neonatal respiratory morbidity after elective caesarean section at term. Cochrane Database Syst Rev. 2018;8(8):CD006614.
   PubMedGoogle Scholar
• Stutchfield P, Whitaker R, Russell I, Antenatal Steroids for Term Elective Caesarean Section (ASTECS) Research Team. Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial. BMJ. 2005;331(7518):662.
   PubMed Web of Science ®Google Scholar
• Gupta K, Rajagopal R, King F, et al. Complications of antenatal corticosteroids in infants born by early term scheduled cesarean section. Diabetes Care. 2020;43(4):906–908.
   PubMed Web of Science ®Google Scholar
• Melamed N, Shah J, Yoon EW, et al. The role of antenatal corticosteroids in twin pregnancies complicated by preterm birth. Am J Obstet Gynecol. 2016;215(4):482.e1–e1482.e9.
   PubMed Web of Science ®Google Scholar
• Bibbo C, Deluca L, Gibbs KA, et al. Rescue corticosteroids in twin pregnancies and short-term neonatal outcomes. BJOG. 2013;120(1):58–63.
   PubMed Web of Science ®Google Scholar
• Kong X, Xu F, Wang Z, et al. Antenatal corticosteroids administration on mortality and morbidity in premature twins born at 25 ∼ 34 gestational weeks: a retrospective multicenter study. Eur J Obstet Gynecol Reprod Biol. 2020;253:259–265.
   PubMed Web of Science ®Google Scholar
• Ushida T, Kotani T, Sadachi R, et al. Antenatal corticosteroids and outcomes in preterm twins. Obstet Gynecol. 2020;135:1387–1397.
   PubMed Web of Science ®Google Scholar
• Dudenhausen JW, Misselwitz B, Piedvache A, EPICE Research Group, et al. Characteristics, management and outcomes of very preterm triplets in 19 European regions. Int J Gynaecol Obstet. 2019;147(3):397–403.
   PubMed Web of Science ®Google Scholar
• Hong S, Lee SM, Kwak DW, et al. Effects of antenatal corticosteroids in twin neonates with late preterm birth (ACTWIN [antenatal corticosteroids in TWIN late preterm neonates] trial): study protocol for a randomized controlled trial. BMC Pregnancy Childhood. 2019;19:114.
   PubMed Web of Science ®Google Scholar
• Battarbee AN, Sandoval G, Grobman WA, for the Eunice Kennedy Shriver National Institute of Child Health Human Development Maternal-Fetal Medicine Units (MFMU) Network, et al. Antenatal corticosteroids and preterm neonatal morbidity and mortality among women with and without diabetes in pregnancy. Am J Perinatol. 2022;39(01):067–074.
   PubMed Web of Science ®Google Scholar
• Werner EF, Romano ME, Rouse DJ, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Network (MFMU)*, et al. Association of gestational diabetes mellitus with neonatal respiratory morbidity. Obstet Gynecol. 2019;133(2):349–353.
   PubMedGoogle Scholar
• Ali H, Salama H, Robertson N, et al. Antenatal corticosteroids and short-term neonatal outcomes in term and near-term infants of diabetic mothers. Analysis of the Qatar PEARL-peristat registry. J Perinat Med. 2020;49:377–382.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence (NICE). NICE Guidance. Diabetes in pregnancy: management from preconception to the postnatal period [NG3]. Retrieved 22 January 2021. Available from: https://www.nice.org.uk/guidance/NG3.
   Google Scholar
• Sukarna N, Tan PC, Hong JGS, et al. Glycemic control following two regimens of antenatal corticosteroids in mild gestational diabetes: a randomized controlled trial. Arch Gynecol Obstet. 2021;304(2):345–353.
   PubMed Web of Science ®Google Scholar
• Kawakita T, Bowers K, Hazrati S, et al. Increased neonatal respiratory morbidity associated with gestational and pregestational diabetes: a retrospective study. Am J Perinatol. 2017;34(11):1160–1168.
   PubMed Web of Science ®Google Scholar
• Crowther CA, Middleton PF, Voysey M, PRECISE Group, et al. Effects of repeat prenatal corticosteroids given to women at risk of preterm birth: an individual participant data meta-analysis. PLoS Med. 2019;16(4):e1002771-e.
   Web of Science ®Google Scholar
• Asztalos EV, Murphy KE, Willan AR, MACS-5 Collaborative Group, et al. Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5). JAMA Pediatr. 2013;167(12):1102–1110.
   PubMed Web of Science ®Google Scholar
• Crowther CA, Anderson PJ, McKinlay CJ, for the ACTORDS Follow-up Group, et al. Mid-Childhood outcomes of repeat antenatal corticosteroids: a randomized controlled trial. Pediatrics. 2016;138(4):e20160947.
   PubMed Web of Science ®Google Scholar
• Zephyrin LC, Hong KN, Wapner RJ, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units (MFMU) Network, et al. Gestational age-specific risks vs benefits of multicourse antenatal corticosteroids for preterm labor. Am J Obstet Gynecol. 2013;209(4):330.e1–7.
   PubMed Web of Science ®Google Scholar
• McKinlay CJ, Cutfield WS, Battin MR, ACTORDS Study Group, et al. Cardiovascular risk factors in children after repeat doses of antenatal glucocorticoids: an RCT. Pediatrics. 2015;135(2):e405-15–e415.
   PubMed Web of Science ®Google Scholar